Zsírmáj (MASLD/MASH): nyitott vizsgálatok itt: Puerto Rico
10 trials · From ClinicalTrials.gov, checked 2026. nov. 10.. Ask the study team whether a trial fits you.
2. fázisToborozTrial-stage medicine
Study to Evaluate ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH)
- Where
- San Juan
- Age
- 18 év to 75 év
- People
- 360 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT07631637EU 2026-525916-33-00Regiszter frissítve: 2026-11-09
3. fázisToborozTrial-stage medicine
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
- Where
- Manati, Mayagüez, San Juan
- Age
- 18 év to 80 év
- People
- 1650 worldwide
- Run by
- Akero Therapeutics, Inc
See details and how to joinNCT06215716Regiszter frissítve: 2026-11-06
3. fázisToborozTrial-stage medicine
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
- Where
- San Juan
- Age
- 18 év and over
- People
- 1800 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06632444EU 2024-513739-25-00Regiszter frissítve: 2026-10-28
3. fázisToborozTrial-stage medicine
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
- Where
- San Juan
- Age
- 18 év and over
- People
- 1590 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06632457EU 2024-513741-36-00Regiszter frissítve: 2026-10-28
3. fázisToborozTrial-stage medicine
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- Where
- Manati, Mayagüez, San Juan
- Age
- 18 év to 80 év
- People
- 1350 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT06318169EU 2023-509912-27-00Regiszter frissítve: 2026-10-23
3. fázisToborozTrial-stage medicine
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- Where
- Manati, Mayagüez, San Juan
- Age
- 18 év to 75 év
- People
- 1800 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT06419374EU 2023-510395-31-00Regiszter frissítve: 2026-10-23
3. fázisToborozTrial-stage medicine
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
- Where
- Manati, Mayagüez, San Juan
- Age
- 18 év to 80 év
- People
- 2150 worldwide
- Run by
- Akero Therapeutics, Inc
See details and how to joinNCT06528314Regiszter frissítve: 2026-10-13
2. fázisToborozTrial-stage medicine
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
- Where
- Guaynabo, San Juan
- Age
- 18 év to 75 év
- People
- 120 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT05519475Regiszter frissítve: 2026-10-08
3. fázisToborozTrial-stage medicine
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
- Where
- Guaynabo, San Juan
- Age
- 18 év and over
- People
- 4500 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07165028EU 2025-522674-36-00Regiszter frissítve: 2026-10-08
3. fázisToborozTrial-stage medicine
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
- Where
- San Juan
- Age
- 18 év to 75 év
- People
- 1200 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07221227Regiszter frissítve: 2026-07-27
Minden vizsgálat (Zsírmáj (MASLD/MASH)) és a térkép
Ez az oldal nem orvosi tanács. Mielőtt egy vizsgálatot megkeresel, beszélj az orvosoddal.